Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amneal Pharmaceuticals Inc (NY: AMRX )

5.260 USD UNCHANGED
Official Closing Price Updated: 4:10 PM EDT, Jun 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 621,034
Open 5.260
Bid (Size) 5.150 (2)
Ask (Size) 5.350 (1)
Prev. Close 5.260
Today's Range 5.185 - 5.290
52wk Range 3.450 - 7.445
Shares Outstanding 1,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for... 
From Business Wire News Releases
Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the Food and Drug Administration recently accepted Amneal’s 505(b)(2) New Drug Application for a newly... 
From Business Wire News Releases

Performance

YTD
+7.79%
+7.79%
1 Month
-6.90%
-6.90%
3 Month
-21.84%
-21.84%
6 Month
+22.33%
+22.33%
1 Year
+2.94%
+2.94%

More News

Read More
Amneal to Virtually Participate at Upcoming Investor Conferences
From Business Wire News Releases
Amneal Reports First Quarter 2021 Financial Results
From Business Wire News Releases
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Amneal Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
From PR Newswire
Amneal's Avastin-Referred Biosimilar Under FDA Review For Colorectal Cancer
Tags General colorectal cancer RHHBF
From Benzinga
Amneal to Report First Quarter 2021 Results on May 7, 2021
From Business Wire News Releases
Amneal Completes Acquisition of Kashiv Specialty Pharmaceuticals
From Business Wire News Releases
12 Health Care Stocks Moving In Friday's After-Market Session
Tags Movers ATOS ONCS
From Benzinga
Earnings Outlook for Amneal Pharmaceuticals
Tags BZI/EP Benzinga Market News
From Benzinga
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2021 Earnings Call Transcript
Tags AMRX Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]